A phase I study of MAGE-A1-targeted T1367 T-cell receptorbased cell therapy in patients with advanced multiple myeloma.
Krüger J, Obenaus M, Blau IW, Hoser D, Vaegler M, Rauschenbach H, Anagnostopoulos I, Jöhrens K, Scheuplein V, Kieback E, Böhme J, Von Brünneck AC, Krönke J, Busse A, Willimsky G, Blankenstein T, Pezzutto A, Keller U, Nogai A.
Krüger J, et al. Among authors: busse a.
Haematologica. 2025 Jan 1;110(1):244-250. doi: 10.3324/haematol.2024.286124.
Haematologica. 2025.
PMID: 39279443
Free PMC article.
No abstract available.